No. However, CCPM has embedded clinical decision support (CDS) tools into UCHealth’s EHR to notify clinicians of gene-drug interactions at the time of prescribing. As of December 2020, clinical decision support is available for ten drug-gene pairs affected by variation in CYP2C19.
Please note that not all medications are metabolized by CYP2C19. For medications that are metabolized by CYP2C19, CYP2C19 genotype does not impact outcomes for all medications to the same extent, or does so in an indication-specific manner.
For further information, please visit Biobank Resources located on the Provider Portal on The Source (UCHealth).
For general information about CYP2C19, click here.